TXG · Healthcare · $11.5B
After-hours $88.40-0.41%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 매출은 1억5,100만 달러로 전 분기와 같아, 1억4,900만→1억6,600만→1억5,100만→1억5,100만 달러로 이어진 흐름상”
In the company's words · 2026 2분기 earnings call